Elevai Labs Balance Sheet Health
Financial Health criteria checks 5/6
Elevai Labs has a total shareholder equity of $8.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $11.2M and $2.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.43m |
| Equity | US$8.56m |
| Total liabilities | US$2.65m |
| Total assets | US$11.21m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ELAB's short term assets ($8.2M) exceed its short term liabilities ($2.1M).
Long Term Liabilities: ELAB's short term assets ($8.2M) exceed its long term liabilities ($519.7K).
Debt to Equity History and Analysis
Debt Level: ELAB is debt free.
Reducing Debt: ELAB had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ELAB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ELAB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 53.8% each year